SpaceX, Adding It Up — The $235 Billion Cash Gap
CapeFearAdvisors
SubscribeSign in
SpaceX, Adding It Up — The $235 Billion Cash Gap<br>Translated into near-term estimated cash requirements, the IPO raise covers a fraction of what the company has disclosed it intends to spend
CapeFearAdvisors<br>May 21, 2026
11
Share
SpaceX disclosed, across the S-1 and adjacent regulatory filings, cash commitments of approximately $235 billion through 2030. The IPO will raise $50 to $75 billion gross. The first $20 billion is contractually committed to debt repayment within six months of closing. The gap is three to five times the raise on items disclosed in the document. Each commitment is correct within its own filing. None are aggregated. The set is not coherent. The question the S-1 does not answer, and that no single forward-looking section is required to address: where this amount of cash can be raised.
Recent updates and news
Six things came into focus since our May 10 piece on the cash gap:<br>The S-1 itself, filed May 20, with detailed segment reporting and forward commitment disclosures.
The IPO raise range: $50–75 billion gross. Valuation rumor at $1.75 trillion or above.
The Anthropic contract: $1.25 billion per month through May 2029, 90-day cancellable. $45 billion headline against capacity that does not yet exist.
The Bridge Loan terms: $20 billion at SOFR plus 0.75–1.75%, effective rate 4.58% as of March 31, 2026, executed March 2 to retire xAI and X debt at 9.5–12.5%. Covenanted to be repaid within six months of IPO proceeds receipt. Cost of the swap in Q1 2026: $1.163 billion in cash prepayment penalties and a $1.526 billion accounting loss on extinguishment.
The Cursor option mechanics: 30-day call window opening seven trading days after IPO completion or September 30, 2026, whichever is earlier. Exercise consideration $60 billion in Class A common stock per the disclosed terms. Termination consequence $1.5 billion termination fee plus $8.5 billion deferred services fee in cash.
The Grimes County tax abatement filing, May 6: Terafab Phase 1 at $55 billion, full buildout to $119 billion. Filed fourteen days before the S-1 disclosed no contractual Terafab commitment.
The estimated cash requirements, item by item
Putting every commitment in the same currency — necessary cash through 2030:
Total: approximately $235 billion in known cash and equity deployment through 2030.<br>The raise: $50–75 billion headline gross. After fees and Bridge Loan retirement, net usable in the $30–50 billion range.<br>The gap is 3 to 5 times the raise on these items alone.<br>Thanks for reading! Subscribe for free to receive new posts and support my work.
Subscribe
How this works
Each item above is disclosed. None are aggregated. Each appears in a different section of the document, structured in a different form.<br>The Bridge Loan repayment is in the debt footnote. Use of Proceeds, where investors read about what the IPO funds, omits it. Investors reading only Use of Proceeds will not know that $20 billion is contractually committed to debt repayment within six months of closing.<br>The Anthropic contract is presented as forward revenue. The capex required to deliver the capacity Anthropic has purchased is folded into AI segment capex aggregated at $12.7 billion for 2025 and $7.7 billion for Q1 2026. Current COLOSSUS plus COLOSSUS II capacity is roughly 1.0 gigawatt total — supporting approximately 510,000 GPUs at 80 percent utilization. The S-1 says COLOSSUS II is being expanded to train Grok 5. Fulfilling Anthropic requires hundreds of thousands of additional GPUs of capacity, financed by capex the IPO is supposed to fund, against a contract Anthropic can cancel at 90 days.<br>The Cursor option is presented as an upside acquisition opportunity. The economic substance is something different. Exercise consideration is $60 billion in Class A common stock — equity dilution, not cash. Termination consequence is $10 billion in cash, payable as a $1.5 billion termination fee plus an $8.5 billion deferred services fee. Both outcomes are material. Whether the company can pay the termination amount in cash is the binding constraint that determines which outcome occurs.<br>Working from the March 31, 2026 balance sheet: $15.85 billion in cash plus $7.82 billion in marketable securities, against a $20 billion Bridge Loan repayment due within six months of IPO proceeds receipt, plus an $11.5 billion Spectrum cash component closing November 2027, plus Valor lease payments at approximately $3.4 billion per year, against a Q1 2026 free cash flow run rate of negative $36 billion per year. The $10 billion termination fee, added on top, is not comfortably payable in cash.<br>Which means the exercise decision is effectively pre-determined by cash constraint, not strategic merit. The 30-day call window opens seven trading days after IPO closing, expiring no later than the end of October 2026. Exclusivity prevents Cursor from accepting competing bids during the...